METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for METASTATIC CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a new drug (DS3201) combined with an immunotherapy (ipilimumab) in people with advanced prostate, bladder, or kidney cancer that has spread. The goal is to find the safest dose and see if the combination can help control the cancer. About 65 adults wi…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:23 UTC
-
New hope for kidney cancer: two drug regimens battle after immunotherapy fails
Disease control OngoingThis study tests two different drug treatments for people with advanced kidney cancer that has spread and continued to grow despite prior immunotherapy. About 90 participants will receive either a combination of two drugs (lenvatinib plus everolimus) or a single drug (cabozantini…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:18 UTC
-
New hope for kidney cancer patients who Can't take standard drugs
Disease control ENROLLING_BY_INVITATIONThis study tests a new medicine called AK112 for people with advanced kidney cancer that has spread. The drug helps the immune system fight cancer and blocks blood vessels that feed tumors. About 60 patients will receive the drug every three weeks to see if it shrinks tumors and …
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
Gut bacteria boost may help kidney cancer drugs work better
Disease control OngoingThis early-phase study looks at whether adding a probiotic called CBM588 to the usual two-drug treatment (cabozantinib and nivolumab) can improve outcomes for people with advanced kidney cancer that has spread. The probiotic is meant to increase helpful gut bacteria, which may he…
Matched conditions: METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 04:11 UTC